Skin test could reveal Parkinson's progression
NCT ID NCT06621602
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses a small skin sample to measure levels of a protein linked to Parkinson's disease and REM sleep behavior disorder. Researchers will follow 100 participants for 18 months to see if changes in the protein match disease progression. The goal is to develop a simple biomarker test to track the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple skin test to monitor Parkinson's disease progression and help develop new treatments.
What could go wrong
This is an early observational study with only 100 participants, so results may not apply to everyone. The protein levels in skin may not reliably reflect brain changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta NeuroScience Institute ANI
Atlanta, Georgia, 30327, United States
-
Aventura Neurologic Associates, LLC
Aventura, Florida, 33180, United States
-
Boston Neuro Research Center
Boston, Massachusetts, 02747, United States
-
CND Life Sciences
Scottsdale, Arizona, 85258, United States
-
Cedars Sinai
Los Angeles, California, 90048, United States
-
MedStar Montgomery Medical Center
Olney, Maryland, 20832, United States
-
Movement Disorders Center of Arizona
Scottsdale, Arizona, 85258, United States
-
Neurology Multidisciplinary Clinic at Norton Healthcare
Louisville, Kentucky, 40241, United States
-
Parkinson's Disease and Movement Disorders Center - Boca Raton
Boca Raton, Florida, 33486, United States
-
Parkinson's Disease and Movement Disorders Center at KUMC
Kansas City, Kansas, 66160, United States
-
Parkinson's Research Centers of America - Long Island
Commack, New York, 11725, United States
-
Parkinson's Research Centers of America - Orange County
Aliso Viejo, California, 92656, United States
-
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California, 94301, United States
-
The Medical University of South Carolina
Charleston, South Carolina, 29403, United States
-
UT Health San Antonio
San Antonio, Texas, 78229, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Rochester
Rochester, New York, 14618, United States
-
Veracity Neuroscience LLC
Memphis, Tennessee, 38157, United States